4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000029
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:36 PM ET
Size
25.2 KB
Accession
0001267399-04-000029
Insider Transaction Report
Form 4
THERASENSE INCTHER
LIAMOS CHARLES T
DirectorCOO and CFO
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$22.00/sh−25,000$550,000→ 0 totalExercise: $5.00From: 1988-08-08Exp: 2010-09-29→ Common Stock (25,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$19.91/sh−13,000$258,830→ 0 totalExercise: $7.09From: 1988-08-08Exp: 2013-02-25→ Common Stock (13,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.00/sh−40,500$931,500→ 0 totalExercise: $4.00From: 1988-08-08Exp: 2010-07-31→ Common Stock (40,500 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$18.00/sh−37,400$673,200→ 0 totalExercise: $9.00From: 1988-08-08Exp: 2011-08-03→ Common Stock (37,400 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−85,880$2,318,760→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.80/sh−41,621$283,023→ 0 totalExercise: $20.20From: 1988-08-08Exp: 2014-01-05→ Common Stock (41,621 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$24.00/sh−45,000$1,080,000→ 0 totalExercise: $3.00From: 1988-08-08Exp: 2010-03-17→ Common Stock (45,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$17.20/sh−20,000$344,000→ 0 totalExercise: $9.80From: 1988-08-08Exp: 2012-12-13→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$3.20/sh−90,000$288,000→ 0 totalExercise: $23.80From: 1988-08-08Exp: 2011-12-14→ Common Stock (90,000 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F2]This option provided for vesting over a four year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F3]Includes 4,180 shares acquired under the TheraSense, Inc. Employee Stock Purchase Plan on April 2, 2004.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:36 PM ET
- Size
- 25.2 KB